A Phase I Study of Alemtuzumab Delivered Intraperitoneally in Patients With Relapsed Ovarian Cancer

This study is currently recruiting participants.

Study NCT00637390 Information provided by University of Michigan Cancer Center

First Received: March 10, 2008 Last Updated: October 4, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2012
Estimated Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)